Table 3. Pathologic characteristics and treatment at the time of endometrial cancer progression.
Characteristics | Patient No. 1 | Patient No. 4 | Patient No. 9 | Patient No. 19 | Patient No. 22 | |
---|---|---|---|---|---|---|
Tumor grade | 3 | 1 | 2 | 1 | 3 | |
Myometrial invasion | <50% | <50% | <50% | <50% | >50% | |
Lymph vascular space invasion | Absent | Absent | Absent | Absent | Present | |
Tumor size (cm) | >2 | <2 | <2 | <2 | >2 | |
Cervical involvement | Absent | Absent | Present | Absent | Absent | |
Adnexal involvement | Absent | Absent | Absent | Synchronous OC | Present | |
Lymphadenectomy | Pelvic | n/p | n/p | Pelvic and para-aortic | Pelvic | |
Lymph node involvement | Absent | n/a | n/a | Absent | Present | |
No. of positive nodes/total no. of lymph nodes removed | 0/21 | 0/19 | 1/17 | |||
Metastatic pattern (mm) | n/a | n/a | >2 | |||
Adjuvant therapy after definitive surgery | n/p | n/p | n/p | Yes | Yes |
n/a, not applicable; n/p, not performed; OC, ovarian cancer.